Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer
Xuechao Liu,1,2,* Pengfei Xu,1,3,* Haibo Qiu,1,2,* Jianjun Liu,1,2 Shangxiang Chen,1,2 Dazhi Xu,1,2 Wei Li,1,2 Youqing Zhan,1,2 Yuanfang Li,1,2 Yingbo Chen,1,2 Zhiwei Zhou,1,2 Xiaowei Sun1,2 1Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innova...
Main Authors: | Liu X, Xu P, Qiu H, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, Sun X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-02-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-utility-of-her2-assessed-by-immunohistochemistry-in-patients--peer-reviewed-article-OTT |
Similar Items
-
Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer
by: Chen Xu, et al.
Published: (2017-05-01) -
Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancer
by: Sun X, et al.
Published: (2016-07-01) -
Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resectable HER2 + Advanced Gastric Cancer: A Retrospective Study
by: Tong G, et al.
Published: (2020-04-01) -
Multi‐institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer
by: Mitsuro Kanda, et al.
Published: (2019-09-01) -
Clinicopathological features and Borrmann classification associated with HER2-positive in primary gastric cancer
by: Dai X, et al.
Published: (2019-06-01)